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doi:10.1016/j.ejvs.2011.01.003Abstract Introduction: Quality of care and learning effect surveillance are two mandatory
responsibilities within a changing therapeutical paradigm. We aimed to evaluate the feasibility
and value of CUSUM chart method in assessing performance in consecutive endovascular proce-
dures done by vascular surgeons of a single department on aorto-iliac, femoropopliteal and
renal artery occlusive disease.
Material and method: Data were collected in 405 consecutive patients, scheduled for endovas-
cular intervention of aorto-iliac (n Z 131, 32.3%), femoropopliteal (n Z 142, 35%) and renal
artery (n Z 132, 32.7%) occlusive disease during a 6-year period. Quality indicators included
inability to cross the lesion, peri- and post-procedural complications and significant residual
stenosis or occlusion at 1 month. CUSUM curves were generated for each territory globally
and according to each quality indicator. The relevance of curve upward inflections was evalu-
ated with Fisher’s Exact Test.
Results: Failure to cross the lesion occurred in 6.9% (aorto-iliac), 10.6% (femoropopliteal) and
2.3% (renal) of patients. One-hundredth twenty aorto-iliac, 127 femoropopliteal and 132 renal
angioplasties were finally performed. Peri- and post-procedural complications appeared in
14.5% (aorto-iliac), 9.2% (femoropopliteal) and 2.3% (renal), while significant residual stenosis
or occlusion was seen in 0.8%, 4.9% and 2.3% of patients, respectively. Aorto-iliac CUSUM curve
showed two upward inflections at the beginning and the end of the period, both associated
with peri- and post-procedural complications (p Z 0.002 and p Z 0.0013) and the latter also
with failure to cross the lesion (p Z 0.009). Femoro-popliteal CUSUM curve moved progres-
sively upward during all the period, initially related to peri- and post-procedural complications
(pZ 0.038) and later to failure to cross the lesion (pZ 0.004). Renal CUSUM curve didn’t show
any upward inflection during the analysed period.
Conclusion: CUSUM curves are an excellent tool for measuring learning effect and quality of
care within a changing paradigm, such it is the case of endovascular interventions. Curve2483223.
lmar.cat (A. Clara´).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
680 L. Calsina et al.upward inflections can be further interpreted according to the type of “failure” thus helping to
evaluate their underlying causes.
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surgical repair as the first revascularisation choice for most
peripheral arterial occlusive disorders. This transition
towards endovascular techniques is being characterised by
the development of new materials, changing indications
and the need to acquire new skills within a frame of
uncertainty about the durability and costs of such inter-
ventions. Importantly, there is a tacit commitment among
professionals to keep efficacy and safety competitive in
relation to open surgery. Within this paradigm shift, quality
of care and learning effect surveillance of endovascular
procedures have become two mandatory responsibilities of
vascular specialists.
A first step towards measuring the learning effect and
quality of care in endovascular procedures is to select
quality indicators. Patency, survival and peri- and post-
procedural complications have long been regarded as the
main outcome measures of vascular reconstruction,
although more recently quality of life, geriatric scales or
economic analyses1e5 have been used as quality end points
as well. In addition, the ability to complete the endovas-
cular procedure, basically to cross the occlusive lesion, may
be considered as a new quality indicator.
Time-series analysis methods report graphs of changes in
outcome rates over time and may seem particularly prom-
ising for monitoring quality indicators. Among these,
cumulative sum (CUSUM) charting,6e11 developed during
World War II as a quality control test in munitions produc-
tion lines,12 is a visual method that allows to easily estab-
lish whether a production process is “in control” or has
become “out of control”. CUSUM charting has been found
effective for measuring and monitoring surgical out-
comes,13e19 yet to our knowledge little attention has been
paid to this methodology for monitoring performance in
endovascular procedures.
The Vascular Surgery Department of the Hospital del
Mar, Barcelona, Spain, has a continuously fed database of
diagnostic and interventional procedures done by vascular
surgeons in an endovascular suite. The objective of this
study was to determine whether CUSUM charts could be
used to identify changes in three quality indicator rates
(ability to cross the lesion, peri- and post-procedural
complications’ rate and 30-day patency) in endovascular
revascularisation procedures on aorto-iliac, femo-
ropopliteal and renal arterial occlusive disorders over a 6-
year period.
Patients and Methods
Between June 2003 and December 2009, 405 consecutive
patients with aorto-iliac (nZ 131, 32.3%), femoropopliteal
(n Z 142, 35%) or renal (n Z 132, 32.7%) artery occlusive
disorders (stenosis or occlusion) were scheduled for inter-
vention at the endovascular suite of the Hospital del Mar,
Barcelona (Spain), equipped with a Siemens AXIOM Artis
equipment.All procedures were performed under local or regional
anaesthesia by a senior endovascular expert (F.V.B.) or by
other less endovascularly experienced attendant vascular
surgeons, or residents, directly supervised by him. By the
time the endovascular suite was built (June 2003), the
team’s accumulated endovascular experience in such
territories with a portable C-arm X-ray device in the oper-
ating room consisted of 97 aorto-iliac and 55 renal cases.
Femoropopliteal endovascular procedures were initiated
within the period of study.
For each patient demographic (age and sex) datum,
artery occlusive disease location, procedural characteris-
tics (access site, technique and material) and peri- and
post-procedural quality indicators (inability to cross the
lesion, peri- and post-procedural complications and signif-
icant residual stenosis or occlusion at 1 month) were
collected from clinical charts and entered into a Statistical
Package for Social Sciences (SSPS) database.
CUSUM charting
CUSUM curve represents the consecutive performance of an
individual or a team displayed as a line chart with the X-axis
representing the consecutive series of procedures and the
Y-axis representing the CUSUM score. Mathematically, the
CUSUM score is defined by the cumulative sum of Xi e Xo,
where Xi represents the success or failure of each consec-
utive procedure. In our model, a score of ‘0’ for each
success and of ‘1’ for the occurrence of a quality indicator
(inability to cross the lesion, peri- or post-procedural
complication or significant residual stenosis or occlusion at
1 month) were assigned to each endovascular attempt. Xo,
on the other hand, represents the procedural inherent risk,
that is, the risk related to the nature of the procedure,
which is estimated from published work. A procedural
inherent risk (Xo) of 0.12 (12%) was thus assumed for both
aorto-iliac and femoropopliteal endovascular interventions
and of 0.05 (5%) for the endovascular treatment of renal
artery stenoses.20e22
The basic principle of the CUSUM curve is that of reward
or punishment with each consecutive attempt, according to
the inherent risk of the procedure. In our model, for
example, the occurrence of a quality indicator in each
aorto-iliac or femoropopliteal endovascular procedure
accounted for an Xi e Xo Z (1e0.12) Z þ0.88 (upwards)
inflection in the curve, whereas each success determined
an Xi e Xo Z (0e0.12) Z 0.12 (downwards) inflection. In
a scenario in which the real procedural risk equals its
theoretical risk, for instance, a consolidated procedure
without a learning effect at play, downward inflections
would compensate upward ones and the CUSUM curve
would run roughly parallel to the X-axis, whereas, for any
real procedural risk over its inherent risk, the CUSUM curve
would move progressively upwards.
Curve upward tendencies may reflect a learning process,
case-mix, new indications or changes in the procedure,
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were done for each territory, taking into consideration only
one quality indicator (inability to cross the lesion, peri- or
post-procedural complications or significant residual
stenosis or occlusion at 1 month). For each of these sub-
analyses, one-third of the inherent procedural risk (Xo)
associated with each territory was assumed.
Statistical analysis
Statistical comparisons between a team’s experience and
theability to improvequality indicatorswereperformedwith
Fisher’s exact test. Cut-off values were chosen according to
the points of inflection revealed by the plots. A p value of
0.05 or less was considered statistically significant.
Results
Among the 131 patients (mean age 67.8 years, 93.8% male)
scheduled for an aorto-iliac endovascular procedure for
stenotic or occlusive disease, 120 angioplasties (117 with
stent) were finally performed, thus accounting for a 6.9%
rate (nine patients) of uncompleted procedures (inability to
cross the lesion). Peri- and post-procedural complications
(Table 1) were seen in 19 patients (14.5%) and significant
residual stenosis or occlusion at 1 month in one case (0.8%).
Among 142 subjects (mean age 74.1 years, 57.8% male)
with femoropopliteal stenosis orocclusions, 127angioplasties
were done, of which 119 were with stent. There was a 10.6%
rate (15 patients) of uncompleted procedures (inability to
cross the lesion). Peri- or post-procedural complications
occurred in 13 patients (9.2%) and significant residual stenosis
or occlusion at 1 month in seven cases (4.9%).
Finally, among those 132 patients (mean age 66.9 years,
73.3% male) scheduled for a renal artery intervention, 129
angioplasties, 109 with stent, were performed. Uncom-
pleted procedures accounted for a 2.3% (three cases), peri-
or post-procedural complications occurred in 2.3% (three
cases) and 1-month patency was 97.7%.
CUSUM charts
Aorto-iliac CUSUM curves (Fig. 1) showed two upward
inflections: one at the beginning related to peri- and post-Table 1 Peri- and post- endovascular procedural quality indica
Aorto-Iliac cases (%)









Significant residual stenosis or
occlusion at 1 month
1 (0.8%)
Failure to cross the lesion 9 (6.9%)procedural complications and another one at the end of the
period of study associated with both peri- and post-proce-
dural complications (p Z 0.002) and inability to cross the
lesion (p Z 0.013).
The femoropopliteal CUSUM general curve (Fig. 2)
showed a continuous upward tendency all over the period
of study. When specific CUSUM charts were plotted,
however, the initial upward tendency was seen to be
associated with peri- and post-procedural complications
(p Z 0.038), while the late one was related to inability to
cross the occlusive lesion (p Z 0.004).
Finally, the renal CUSUM curve (Fig. 3) did not show any
upward or downward inflection at all over the 6-year period
of study. Further, CUSUM sub-analysis curves for each
quality indicator did not provide additional valuable
information.
Discussion
Our study has shown the successful application of
a continuously updated, monitoring technique for the
evaluation of the performance of endovascular procedures
in peripheral arterial occlusive disease. Over the 6-year
period of study, several time intervals of lower-than-
expected performance were identified by CUSUM curves.
Further analyses according to each type of quality indicator
determined that both inabilities to cross the occlusive
lesion and peri- or post-procedural complications, but not
immediate patency results, were responsible for such
upward curve tendencies. These quality indicators can be
related to individual or team lack of experience, changes in
materials or in the endovascular procedure or to an
extension of indications to more complex patients. Further
prospective studies are needed to improve our under-
standing of the underlying causes of downshifts in the
performance in novel procedures.
The inclusion of ‘inability to cross the lesion’ as a quality
indicator may be problematic and deserves some comment.
Obviously, it may indicate operator’s lack of experience,
collective uncertainty among vascular specialists or the
insufficiencies of existing materials and devices. Yet,
sometimes ‘inability to cross the lesion’ may be also
deliberate when the operator decides not to force
a guidewire re-entry because a segment of patent arterytors in the population of study.
Femoro-Popliteal cases (%) Renal cases (%)






7 (4.9%) 3 (2.3%)
15 (10.6%) 2 (2.3%)
Figure 1 CUSUM curves of aorto-iliac endovascular interventions: General CUSUM curve shows two upward inflections (arrows)
whose cause is revealed by the specific curves resulting from sub-analyses with each quality indicator.
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alternative jeopardised, as it is considered, for instance, at
our institution. Most of these “unsuccessful” attempts can
be done with no or very little harm to the patient at the
time of obtaining the angiographic data necessary for
surgical planning. However, as the underlying causes of not
crossing the lesion, whether deliberate or not, can beFigure 2 CUSUM curves of femoropopliteal endovascular inter
inflection whose cause is revealed by the specific curves resultingdifficult to elucidate in real practice, it makes sense to
keep this variable as a quality indicator of endovascular
performance.
The knowledge of the inherent risk associated with each
type of endovascular procedure, a requisite of the CUSUM
methodology, is another problematic issue that deserves
additional comments, first, because a procedural riskventions: General CUSUM curve shows a continuous upward
from sub-analyses with each quality indicator.
Figure 3 CUSUM curve of renal endovascular interventions:
No up- or downward inflections were seen in the general or
specific (not plotted) CUSUM curves thus revealing a steady
performance within accepted standards of risk.
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procedural complications and 30-day patency, is seldom
reported in the literature. While patency results are
universally described, the amount and type of peri- and
post-procedural complications are described with great
heterogeneity among studies.23e31 Needless to say that
unsuccessful lesion crossings are only reported in some
prospective studies with cases collected on an intention-to-
treat basis. The inherent risk for each generic type of
endovascular procedure was thus extrapolated from liter-
ature.20e22 After viewing our CUSUM curves, however, these
inherent risks were found to be appropriate for our analyses
of aorto-iliac and renal endovascular cases, but probably
were too optimistic for our femoropopliteal cases, in which
the CUSUM curve showed a steady upward slope over the
whole period of study. CUSUM curves are illustrative of
performance when no upward inflections emerge within
standard accepted risks or when curve inflections alternate
with plateau phases, but are of little value when a steady
upward tendency dominates the curve.
The difficulties in choosing an adequate theoretical risk
for each CUSUM analysis has been reported to be overcome,
not without added complexities, by an adjusted risk asso-
ciated with the type of procedure and features of the
patient.10,11 Other more simple approaches can be also
helpful. For instance, if the assumed risk is first stated at
the highest accepted value and the CUSUM curve shows
a plateau e thus not illustrative e the risk value can then
be moved downwards until curve inflections emerge and
further interpretation of changes in performance can be
done. A different approach, as it was used in this study,
consisted in plotting different CUSUM curves according to
each quality indicator, thus helping to understand the
underlying causes of performance inflections, as was the
case of aorto-iliac and femoropopliteal cases. Renal endo-
vascular CUSUM general and specific curves showed
a plateau since the beginning of the study even at minimal
assumed risk values. This steady performance within
accepted limits can be explained by the predominance of
stenotic rather than occlusive lesions and the previous
experience of the team in such a standardised and rela-
tively easy procedure.
In summary, CUSUM curves appear to be an important
tool for vascular specialists in assessing their endovascular
performance using a real-time, simple and visual method
adjusted by the inherent risk of the procedure. Curve sub-analyses according to predefined quality indicators have
shown to be useful in appraising the underlying causes of
curve upward inflections. Prospective studies are needed to
assess the impact of CUSUM monitoring on endovascular







1 Burke GL, Arnold AM, Bild DE, Cushman M, Fried LP, Newman A,
et al. Factors associated with healthy aging: the cardiovascular
health study. J Am Geriatr Soc 2001;49:254e62.
2 Espinoza SE, Fried LP. Risk factors for frailty in older adult. Clini
Geriatr 2007;15:37e44.
3 Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K.
Validity and reliability of the Edmonton Frail Scale. Age Ageing
2006;35:526e9.
4 Oberkofler CE, Stocker R, Raptis DA, Stover JF, Schuepbach RA,
Mu¨llhaupt B, et al. Same quality e higher price? The paradox of
allocation: the first national single center analysis after the
implementation of the new Swiss transplantation law: the ICU
view. Clin Transplant; 2010 Nov 26. doi:10.1111/j.1399-
0012.2010.01364.x.
5 Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M,
et al. Evaluation of the ventricular assist device programme in
the UK. Health Technol Assess 2006;10(48):1e119. iiieiv.
6 Biau DJ, Resche-Rigon M, Godiris-Petit G, Nizard RS, Porcher R.
Quality control of surgical and interventional procedures:
a review of the CUSUM. Qual Saf Health Care 2007;16:203e7.
7 Morrison JB. Putting the learning curve in context. J Bus Res;
2008. doi:10.1016/j.jbusres.2007.11.009.
8 Lewis S. Towards a general theory of indifference to research-
based evidence. J Health Serv Res Policy 2007;12:166e72.
9 Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF,
Russell IT. Assessment of the learning curve in health technol-
ogies: a systematic review. Int J Technol Assess Health Care
2000;16:1095e108.
10 Bolsin S, Colson M. The use of the Cusum technique in the
assessment of trainee competence in new procedures. Int J
Qual Health Care 2000;12(5):433e8.
11 Noyez L. Control charts, Cusum techniques and funnel plots. A
review of methods for monitoring performance in healthcare.
Interact Cardiovasc Thorac Surg 2009;9:494e9.
12 Siegmund D. Sequential analysis, tests and confidence intervals.
New York: Springer; 1985. p.24e30.
13 Buxton MJ. Problems in the economic appraisal of new health
technology: the evaluation of heart transplants in the UK. In:
Drummond MF, editor. Economic appraisal of health technology
in the European Community. Oxford Medical Publications; 1987.
p. 103e18.
14 Colquhoun PHD. CUSUM analysis of a J-pouch surgery reflects no
learning curve effects in surgical trials. Can J Surg 2008;51:
296e9.
15 Cook JA, Ramsay CR, Fayers P. Statistical evaluation of learning
curve effects in surgical trials. Clin Trial 2004;1:421e7.
16 Boulkedid R, Sibony O, Bossu-Salvador C, Oury JF, Alberti C.
Monitoring healthcare quality in an obstetrics and gynaecology
684 L. Calsina et al.department using a CUSUM chart. BJOG; 2010. doi:
10.1111/k.1471-0528.2010.02632.x.
17 Salowi MA, Choong YF, Goh PP, Ismail M, Lim TO. CUSUM:
a dynamic tool for monitoring competency in cataract surgery
performance. Br J Ophthalmol 2010;94:445e9.
18 TransAtlantic Intersociety Consensus (TASC). Management of
peripheral arterial disease. J Vasc Surg 2000;31:S97.
19 TASC Working Group. Endovascular procedures for intermittent
claudication. J Vasc Surg 2000;31:S97e113.
20 Rholl KS. Percutaneous aortoiliac intervention in vascular
disease. In: Baum S, Pentecost MJ, editors. Abram’s angiog-
raphy: interventional radiology. Boston: Little, Brown; 1997. p.
225e61.
21 Martin EC. Femoropopliteal revascularization. In: Baum S,
Pentecost MJ, editors. Abram’s angiography: interventional
radiology. Boston: Little, Brown; 1997. p. 262e83.
22 Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC,
van Dijk LC, Deinum J, Man In’t Veld AJ. Stent placement for
renal arterial stenosis: where do we stand? A meta-analysis.
Radiology 2000;216:78e85.
23 Johnston KW, Rae M, Hogg-Johnston SA, Colapinto RF,
Walker PM, Baird RJ, et al. Five-year results of a prospective
study of percutaneus transluminal angioplasty. Ann Surg 1987;
206:403.24 Johnston KW. Iliac arteries: reanalysis of results of balloon
angioplasty. Radiology 1993;186:207.
25 Rutherford RB. Options in the surgical management of aorto-iliac
occlusivedisease:achangingperspective.CardiovascSurg1999;7:5.
26 Schermerhorn ML, Cronenwett JL, Baldwin JC. Open surgical
repair versus endovascular therapy for chronic lower extremity
occlusive disease. Annu Rev Med 2003;54:269.
27 Ali AT, Modrall JC, Lopez J, Brawley JG, Welborn MB,
Clagett GP, et al. Emerging role of endovascular grafts in
complex aortoiliac occlusive disease. J Vasc Surg 2003;38:486.
28 Pentecost MJ, Criqui MH, Corros G, Goldstone J, Johnston KW,
Martin EC, et al. Guidelines for peripheral percutaneous
transluminal angioplasty of the abdominal aorta and lower
extremity vessels. Circulation 1994;89:511e31.
29 Muradin GS, Bosch JL, Stijnec T, Hunink MGM. Balloon dilatation
and stent implantation for treatment of femoropopliteal arte-
rial disease: meta-analysis. Radiology 2001;221:137e45.
30 Tegtmeyer CJ, Kellman CD, Ayers C. Percutaneous transluminal
angioplasty of the renal artery. Results and long-term follow-
up. Radiology 1984;153(77):84.
31 Raynaud AC, Beyssen BM, Turmel-Rodrigues LE, Pagny JY,
Sapoval MR, Gaux JC, et al. Renal artery stent placement:
immediate and midterm technical and clinical results. J Vasc
Interv Radiol 1994;5:849e58.
